Life Science

Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Regular price $210.00 USD
Regular price Sale price $210.00 USD
Sale Sold out
Published Date
Length Pages
SKU

Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
Summary

Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Astex Pharmaceuticals, Inc. (Astex or ‘the company’), a member of Otsuka Group, discovers, develops and commercializes cancer and central nervous system (CNS) therapies. It offers oncology product portfolio with multiple drugs in mid-late stage clinical development worldwide and CNS product portfolio of novel targeted therapeutics for defined neurodegenerative disease populations. Its product pipeline includes), a next generation DNA-hypomethylating agent; ASTX727, TAS1553, TAS1440, Azacitidine and Cedazuridine (ASTX030), an oral DNMT (DNA methyltransferase) inhibitor; ASTX029, an inhibitor of ERK 1/2; and ASTX660, a dual IAP (inhibitors of apoptosis proteins) antagonist. Astex has business presence in the UK and the US. The company is headquartered in Pleasanton, California, the US.

ScopeDetailed information on Astex Pharmaceuticals, Inc. required for business and competitor intelligence needsA study of the major internal and external factors affecting Astex Pharmaceuticals, Inc. in the form of a SWOT analysisAn in-depth view of the business model of Astex Pharmaceuticals, Inc. including a breakdown and examination of key business segmentsIntelligence on Astex Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisorsNews about Astex Pharmaceuticals, Inc., such as business expansion, restructuring, and contract winsLarge number of easy-to-grasp charts and graphs that present important data and key trendsReasons to buyGain understanding of Astex Pharmaceuticals, Inc. and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.Assess Astex Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.Support sales activities by understanding your customers' businesses better.Stay up to date on Astex Pharmaceuticals, Inc.'s business structure, strategy and prospects.

View full details